<DOC>
	<DOCNO>NCT01078844</DOCNO>
	<brief_summary>The purpose study see memantine helpful manage problematic symptom adult autism , Asperger 's disorder , Pervasive Developmental Disorder NOS .</brief_summary>
	<brief_title>Memantine Adult Autism Spectrum Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Child Development Disorders , Pervasive</mesh_term>
	<mesh_term>Developmental Disabilities</mesh_term>
	<mesh_term>Asperger Syndrome</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<criteria>Inclusion criterion Participant currently treatment JHBMC ASNC Participant diagnosis : Autistic Disorder Asperger 's Disorder PDD NOS Participant meet one follow criterion : CGIS &gt; = 4 ( CGIS : ________ ) Participant follow problematic behavior ( least one ) might expect benefit memantine : 1 . _____________________________________________ 2 . _____________________________________________ 3 . _____________________________________________ Exclusion criterion The patient meet none follow criterion ( mark absent ) : Active seizure ( Patients history seizure , seizurefree antiepileptic regimen six month would eligible ) . Rett 's Syndrome Childhood Disintegrative Disorder Active treatment acetylcholinesterase inhibitor Prior current treatment memantine Current treatment lamotrigine Genetic , metabolic degenerative disorder ( except Fragile X ) . Brain malformation know severe brain trauma Pregnancy breastfeed GFR &lt; 30 mL/min</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Autism</keyword>
	<keyword>Asperger 's Disorder</keyword>
	<keyword>Pervasive Developmental Disorder NOS</keyword>
	<keyword>Adult</keyword>
	<keyword>Memantine</keyword>
</DOC>